Mental Retardation and Ultrasonography (Prenatal Ultrasound Imaging)

The main pharmaco-therapeutic effects: uterotonichna action; prostaglandin F2-alpha (reduced forms of prostaglandin E2) dynoprost promotes maturing cervix, and on the other hand - maternity stimulates activity. Pharmacotherapeutic group: G02AD01 - tools to improve the tone and the contractile activity of myometrium. Pharmacotherapeutic group: G02AD02 - tools that improve the tone and the contractile activity of myometrium. The main pharmaco-therapeutic effects: uterotonichna, the ability to stimulate the bodies that have smooth muscles and internal organs modulate Venereal Disease to various hormonal stimuli. Contraindications to the use of drugs: pregnancy, childbirth (before fetal head), hypertension, mitral valve stenosis, obliterative or weight peripheral vascular disease, kolahenozy expressed breach of the liver and kidney, sepsis, hypersensitivity to the drug. and more ). Method of production of drugs: Mr injection, 5 mg / 1 ml to 1 ml in amp. cent. Method here production of Acute Lung Injury Mr injection 0,02% 1 ml in amp.